Name: Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation (Video) | JoVE Journal
Uploaded: 2022-07-27T12:50:00.000+00:00
Duration: 8 min 34 s
Description: Learn to establish a DSS-induced colitis model in antibiotic-treated mice to evaluate Bacillus cereus probiotic effects. This method reveals how gut microbiota mediates protective outcomes in inflammatory bowel disease research.

ai_agent_IP

ai_agent

maintenance

instantTrialDurationMinutes

isBiopharma

enableNewMyJoveSectionDesign

educationFeatures

seoMetaApi

ai_copilot_institution_blacklist

ai_chat_institution_blacklist

freeAccessWindow

ssoRoleCapture

scheduledMaintenanceBanner

joveLabsFeatures

disable_autoplay_for_bots

extended_trial_duration

5 minutes

This study was supported at least in part by the National Natural Science Foundation of China (K.S., grant No. 32000081), the Natural Science Foundation of Anhui Province (K.S., grant No. 1908085QC120), the Open Project Program of State Key Laboratory of Food Science and Technology, Jiangnan University (K.S., grant No.SKLF-KF-201920), the Natural Science Foundation of Anhui Higher Education Institutions of China (K.S., grant No. KJ2019A0040), the Doctoral Scientific Research Foundation of Anhui University (K.S., grant No. J01003316 ), the National Natural Science Foundation of China (Y.W., grant Nos. 31770066, 31470218), the Open fund for Discipline Construction, Institute of Physical Science and Information Technology of Anhui University (Y.W.), and the Outstanding Talents Program of Anhui University, China (Y.W.).

All procedures were carried out in accordance with the Guidelines for Care and Use of Laboratory Animals of Anhui University, China, and all procedures were approved by the Animal Ethics Committee of Anhui University, China (No. IACUC(AHU)-2020-014).
1. Administration of antibiotics
<ol>
	<li>Prepare a cocktail of antibiotics by dissolving ampicillin (1 g/L), neomycin sulfate (1 g/L), metronidazole (0.5 g/L), and vancomycin (0.5 g/L) in 1 L of drinking water5.</li>
	<li>After complete dissolution, store the solutions at 4 &#176;C.</li>
	<li>Put the antibiotic cocktail solutions into a water bottle. Place the bottle on top of the mouse cage. 
	NOTE: Ensure to use brown bottles or wrap the bottles with aluminum foil to protect the antibiotic solutions from light.</li>
	<li>Replace the antibiotic cocktail with fresh solutions 2x per week.</li>
	<li>Allow the mice to drink the antibiotic cocktail solutions freely for 4 weeks.</li>
</ol>
2. Preparation of DSS drinking water and induction of colitis
<ol>
	<li>To make a 2.5% dextran sulfate sodium (DSS) solution, dissolve 2.5 g of DSS in 100 mL of distilled water11.</li>
	<li>Replace the drinking water with the 2.5% DSS solution in the colitis model mice group. Ensure that the mice in the colitis group&#160;have no access to other drinking water. Meanwhile, treat the control mice with distilled water without DSS.</li>
	<li>House male C57BL/6J mice (average body weight, 20 g &#177; 2 g; aged 7 weeks) under pathogen-free conditions with free access to standard food and water. 
	NOTE: House a total of five mice per cage under pathogen-free conditions.</li>
	<li>Experimental design 
	NOTE: The animal experiments were designed in two stages. Five mice were included for each group.
	<ol>
		<li>First stage: To assess the positive effect of B. cereus on alleviating colitis, randomly assign the mice to the following three groups: control group (control), DSS-induced colitis model (DSS), probiotic B. cereus supplementation for DSS-induced mice (B. cereus).</li>
		<li>Second stage: To explore the role of gut microbiota in regulating the probiotic effects of B. cereus on DSS-induced colitis, randomly assign the mice into the following three groups: ABX (control), ABX (DSS), and ABX (B. cereus + DSS).
		<ol>
			<li>Treat the mice in the ABX (control) group with physiological saline.</li>
			<li>After treatment with antibiotic cocktail solutions for 4 weeks, let the mice in the ABX (DSS) group receive water containing 2.5% DSS for 1 week and normal physiological saline for 2 weeks.</li>
			<li>After treatment with antibiotic cocktail solutions and DSS water, treat the ABX (B. cereus + DSS) group mice daily with B. cereus (2 x 108 cells) in 200 &#181;L of physiological saline using an intragastric cannula for 2 weeks.</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>After the administration of the antibiotic cocktail, immediately treat the male C57BL/6 mice with 2.5% DSS solution in drinking water for 7 days.</li>
	<li>Record the bodyweight of the mice before the DSS intervention as the baseline weight.</li>
</ol>
3. Quantification of&#160;&#160;B. cereus 
<ol>
	<li>Prepare eight 1.5 mL microcentrifuge tubes filled with 900 &#181;L of sterile normal saline.</li>
	<li>Pipette 100 &#181;L of logarithmic growth B. cereus and dissolve in 900 &#181;L of sterile normal saline.</li>
	<li>Serially dilute B. cereus using tubes.</li>
	<li>Plate 40 &#181;L of each dilution onto the respective LB agar plate labeled with the dilution ratio. Repeat 3x for each dilution ratio.</li>
	<li>Culture the plates in a 37 &#176;C constant temperature incubator for 16 h.</li>
	<li>Select the plates with ~20-70 colonies for counting. Calculate the average bacterial concentration according to the dilution multiple of the selected plates.</li>
</ol>
4. Preparation of B. cereus for gavage
<ol>
	<li>After the quantification of B. cereus, collect 1 mL of B. cereus medium containing 1 x 109 CFU and centrifuge at 8,000 x g for 10 min. Then, wash the bacterial cells 2x with sterile water by centrifugation at 8,000 x g for 10 min and remove the supernatant.</li>
	<li>Dilute the concentrated B. cereus with sterile normal saline to a final concentration of 2 x 108 CFU/200 &#181;L4.</li>
	<li>Pipette the dilution up and down repeatedly to acquire a dispersed B. cereus suspension.</li>
	<li>Carry out the quantification of B. cereus concentration by the plate count technique before completion of the gavage method.</li>
</ol>
5. Application of B. cereus supplements by gavage
<ol>
	<li>Administer the interventions (2 x 108 CFU probiotics in 200 &#181;L of normal saline) into the mice through oral gavage at a fixed time.</li>
	<li>To administer B. cereus, connect a gavage needle (feeding needle size: 20 G, 38 mm) to a 1 mL syringe. Wipe the outside of the gavage needle with 70% ethanol between mice and maintain proper dose application.</li>
	<li>To restrain the mice, pick them up by their tail, and grasp the loose skin of the back firmly with the end of the tail fixed between the handler&#39;s last two fingers.</li>
	<li>Keep the mice in a vertical position. Then, insert the gavage needle carefully and gently through the mouth into the esophagus. If no resistance is met in this step, gently push the needle into the stomach. 
	NOTE: Confirm regular and unimpeded breathing of the mice before drug administration.</li>
	<li>Slowly advance the needle and administer the B. cereus solution. Withdraw the needle gently after the completion of the gavage. Release the mouse and return it to its cage.</li>
</ol>
6. Determination of the disease activity index
NOTE: The disease activity index (DAI) was calculated daily by the mice&#39;s body weight loss, fecal occult blood, and stool consistency.
<ol>
	<li>Measure the bodyweight of the mice daily. Assign a score of 0-4 to each mouse based on the body weight loss percentage (0: 0%, 1: 1%-5%, 2: 6%-10%, 3: 11%-18%, and 4: &#62;18%).</li>
	<li>Collect fresh stool samples from each mouse. Use a cotton swab to stimulate the contraction of the anus to promote defecation. Then, collect the feces samples immediately after defecation in a sterilized centrifuge tube.</li>
	<li>Determine the fecal occult blood by stool occult blood test paper. Collect 10 mg of stool sample on an applicator stick.</li>
	<li>Put the specimen on the test card and apply a thin smear to the card. Open the back flap and apply developer over the smear.</li>
	<li>Then,score for occult blood using stool occult blood test paper within 120 s. 
	NOTE: Any trace of blue on or at the edge of the smear is positive for occult blood. Fecal occult scores were as follows: 0: None, 1: Hemoccult positive, 2: Slight, 3: Blood traces in stool and 4: Gross bleeding.</li>
	<li>Identify the stool consistency by detecting the stool sample11. Assign a score of 0-4 (0: Normal, 1: Loose stools, 2: Semi-formed stools, 3: Liquid stools, and 4: Diarrhea).</li>
</ol>
7. Tissue collection
<ol>
	<li>Anesthetize the mice by intraperitoneally injecting 10% chloral hydrate (10 mg/kg) at the end of the first and second stages of the experiment. Evaluate the depth of anesthesia in mice by the pinch withdrawal reflex.</li>
	<li>Then, euthanize the mice by cervical dislocation.</li>
	<li>Fix the mice supine on the operating table, and open the peritoneal cavity.</li>
	<li>Separate the entire colon surgically and measure the length with a ruler.</li>
	<li>Then, gently wash the colon with a 5 mL syringe filled with precooled PBS.</li>
</ol>
8. Assessment of histological damage
<ol>
	<li>Cut the colon tissue into small fragments, fix them in 4% paraformaldehyde, and embed them in paraffin using a tissue embedding machine.</li>
	<li>Then, section the paraffin-embedded tissues with a microtome to prepare 4 &#181;m thick colonic tissue sections. Dewax and dehydrate the colon sections. Then, stain the colon sections with hematoxylin and eosin (H&#38;E). 
	NOTE: The stained colon samples are assessed by the investigator with a system for the following measures: degree of inflammatory cell infiltration (None: 0, Mild: 1, Moderate: 2, Severe: 3), mucosal damage (None: 0, Mucous layer: 1, Submucosa: 2, Muscularis and serosa: 3), crypt damage (None: 0, 1/3: 1, 2/3: 2, entire: 3, entire + epithelium loss: 4), range of lesions (%) (0%: 0, 1%-25%: 1, 26%-50%: 2, 51%-75%: 3, 76%-100%: 4). The total histological damage score is calculated for each individual score of the above measures5.</li>
	<li>Let two independent experimenters evaluate (blinded) the histological scores of the sample under a light microscope.</li>
</ol>

<ol><li>Pittayanon, R., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Differences+in+gut+microbiota+in+patients+with+vs+without+inflammatory+bowel+diseases%3A+A+systematic+review%5BTitle%5D)+AND+%22Gastroenterology%22%5BJournal%5D)">Differences in gut microbiota in patients with vs without inflammatory bowel diseases: A systematic review.</a> Gastroenterology. 158 (4), 960-946 (2020).</li>
<li>Kuehn, F., Hodin, R. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Impact+of+modern+drug+therapy+on+surgery%3A+Ulcerative+colitis%5BTitle%5D)+AND+%22Visceral+Medicine%22%5BJournal%5D)">Impact of modern drug therapy on surgery: Ulcerative colitis.</a> Visceral Medicine. 34 (6), 426-431 (2018).</li>
<li>Harmand, P. -O., Solassol, J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Thiopurine+drugs+in+the+treatment+of+ulcerative+colitis%3A+Identification+of+a+novel+deleterious+mutation+in+TPMT%5BTitle%5D)+AND+%22Genes%22%5BJournal%5D)">Thiopurine drugs in the treatment of ulcerative colitis: Identification of a novel deleterious mutation in TPMT.</a> Genes. 11 (10), 1212(2020).</li>
<li>Sheng, K., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Synbiotic+supplementation+containing+Bifidobacterium+infantis+and+xylooligosaccharides+alleviates+dextran+sulfate+sodium-induced+ulcerative+colitis%5BTitle%5D)+AND+%22Food+%26+Function%22%5BJournal%5D)">Synbiotic supplementation containing Bifidobacterium infantis and xylooligosaccharides alleviates dextran sulfate sodium-induced ulcerative colitis.</a> Food & Function. 11 (5), 3964-3974 (2020).</li>
<li>Sheng, K., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Probiotic+Bacillus+cereus+alleviates+dextran+sulfate+sodium-induced+colitis+in+mice+through+improvement+of+the+intestinal+barrier+function%2C+anti-inflammation%2C+and+gut+microbiota+modulation%5BTitle%5D)+AND+%22Journal+of+Agricultural+and+Food+Chemistry%22%5BJournal%5D)">Probiotic Bacillus cereus alleviates dextran sulfate sodium-induced colitis in mice through improvement of the intestinal barrier function, anti-inflammation, and gut microbiota modulation.</a> Journal of Agricultural and Food Chemistry. 69 (49), 14810-14823 (2021).</li>
<li>Wei, L., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((PRKAR2A+deficiency+protects+mice+from+experimental+colitis+by+increasing+IFN-stimulated+gene+expression+and+modulating+the+intestinal+microbiota%5BTitle%5D)+AND+%22Mucosal+Immunology%22%5BJournal%5D)">PRKAR2A deficiency protects mice from experimental colitis by increasing IFN-stimulated gene expression and modulating the intestinal microbiota.</a> Mucosal Immunology. 14 (6), 1282-1294 (2021).</li>
<li>Souza, E. L. S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Beneficial+effects+resulting+from+oral+administration+of+Escherichia+coli+Nissle+1917+on+a+chronic+colitis+model%5BTitle%5D)+AND+%22Beneficial+Microbes%22%5BJournal%5D)">Beneficial effects resulting from oral administration of Escherichia coli Nissle 1917 on a chronic colitis model.</a> Beneficial Microbes. 11 (8), 779-790 (2020).</li>
<li>Trinder, M., Daisley, B. A., Dube, J. S., Reid, G. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Drosophila+melanogaster+as+a+high-throughput+model+for+host-microbiota+interactions%5BTitle%5D)+AND+%22Frontiers+in+Microbiology%22%5BJournal%5D)">Drosophila melanogaster as a high-throughput model for host-microbiota interactions.</a> Frontiers in Microbiology. 8, 751(2017).</li>
<li>Liang, W., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Colonization+potential+to+reconstitute+a+microbe+community+in+pseudo+germ-free+mice+after+fecal+microbe+transplant+from+equol+producer%5BTitle%5D)+AND+%22Frontiers+in+Microbiology%22%5BJournal%5D)">Colonization potential to reconstitute a microbe community in pseudo germ-free mice after fecal microbe transplant from equol producer.</a> Frontiers in Microbiology. 11, 1221(2020).</li>
<li>Hernandez-Chirlaque, C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Germ-free+and+antibiotic-treated+mice+are+highly+susceptible+to+epithelial+injury+in+DSS+colitis%5BTitle%5D)+AND+%22Journal+of+Crohns+%26+Colitis%22%5BJournal%5D)">Germ-free and antibiotic-treated mice are highly susceptible to epithelial injury in DSS colitis.</a> Journal of Crohns & Colitis. 10 (11), 1324-1335 (2016).</li>
<li>Sheng, K., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Grape+seed+proanthocyanidin+extract+ameliorates+dextran+sulfate+sodium-induced+colitis+through+intestinal+barrier+improvement%2C+oxidative+stress+reduction%2C+and+inflammatory+cytokines+and+gut+microbiota+modulation%5BTitle%5D)+AND+%22Food+%26+Function%22%5BJournal%5D)">Grape seed proanthocyanidin extract ameliorates dextran sulfate sodium-induced colitis through intestinal barrier improvement, oxidative stress reduction, and inflammatory cytokines and gut microbiota modulation.</a> Food & Function. 11 (9), 7817-7829 (2020).</li>
<li>Xu, X., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Histological+and+ultrastructural+changes+of+the+colon+in+dextran+sodium+sulfate-induced+mouse+colitis%5BTitle%5D)+AND+%22Experimental+and+Therapeutic+Medicine%22%5BJournal%5D)">Histological and ultrastructural changes of the colon in dextran sodium sulfate-induced mouse colitis.</a> Experimental and Therapeutic Medicine. 20 (3), 1987-1994 (2020).</li>
<li>Zheng, L., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Jianpi+Qingchang+decoction+alleviates+ulcerative+colitis+by+inhibiting+nuclear+factor-kappa+B+activation%5BTitle%5D)+AND+%22World+Journal+of+Gastroenterology%22%5BJournal%5D)">Jianpi Qingchang decoction alleviates ulcerative colitis by inhibiting nuclear factor-kappa B activation.</a> World Journal of Gastroenterology. 23 (7), 1180-1188 (2017).</li>
<li>Gao, X., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Symptoms+of+anxiety%2Fdepression+is+associated+with+more+aggressive+inflammatory+bowel+disease%5BTitle%5D)+AND+%22Scientific+Reports%22%5BJournal%5D)">Symptoms of anxiety/depression is associated with more aggressive inflammatory bowel disease.</a> Scientific Reports. 11, 1440(2021).</li>
<li>Thippeswamy, B. S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Protective+effect+of+embelin+against+acetic+acid+induced+ulcerative+colitis+in+rats%5BTitle%5D)+AND+%22European+Journal+of+Pharmacology%22%5BJournal%5D)">Protective effect of embelin against acetic acid induced ulcerative colitis in rats.</a> European Journal of Pharmacology. 654 (1), 100-105 (2011).</li>
<li>Sakai, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Astaxanthin%2C+a+xanthophyll+carotenoid%2C+prevents+development+of+dextran+sulphate+sodium-induced+murine+colitis%5BTitle%5D)+AND+%22Journal+of+Clinical+Biochemistry+and+Nutrition%22%5BJournal%5D)">Astaxanthin, a xanthophyll carotenoid, prevents development of dextran sulphate sodium-induced murine colitis.</a> Journal of Clinical Biochemistry and Nutrition. 64 (1), 66-72 (2019).</li>
<li>Li, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Role+of+gut+microbiota+in+the+anti-colitic+effects+of+anthocyanin-containing+potatoes%5BTitle%5D)+AND+%22Molecular+Nutrition+%26+Food+Research%22%5BJournal%5D)">Role of gut microbiota in the anti-colitic effects of anthocyanin-containing potatoes.</a> Molecular Nutrition & Food Research. 65 (24), 2100152(2021).</li>
</ol>

The authors have nothing to disclose.

In order to use probiotics in clinical studies, it is necessary to evaluate the efficacy and safety of probiotics in animal models. The provided protocols have been previously optimized for evaluating colitis severity. Mice treated with DSS is a model of intestinal inflammation, which mimics the clinical and histological features characteristic of ulcerative colitis12. Acute colitis model mice are characterized by body weight loss, diarrhea, fecal bleeding, and inflammatory cell infiltration<sup c...

Inflammatory bowel diseases (IBDs) are common chronic gastrointestinal inflammatory disorders, including Crohn&#39;s disease and ulcerative colitis (UC)1. The current therapeutic avenues for inflammatory colitis are 5-aminosalicylates, corticosteroids, azathioprine, and antibiotics2. Moreover, these drugs have considerable side effects3. Therefore, we should pay more attention to the effect of probiotics on the treatment of colitis.
Alternative therapeutic approaches include probiotic administration, which has been used in animal models and clinical trials. Previous studies have indicated that different probiotic administration, such as Bacillus cereus or Bifidobacterium infantis, could alleviate colitis4,5. In preclinical studies, the effectiveness and safety of probiotics must be investigated in animal models.
Dextran sulfate sodium (DSS) colitis mouse models can help explore the mechanisms of colitis and evaluate the positive effects of probiotics. The DSS inducement results in erosions of the intestinal mucosa, gut barrier dysfunction, and an increase in intestinal epithelial permeability6. Most mouse models for probiotics have mainly highlighted biological effects. However, the mechanism behind the administration of this probiotic is challenging to explore, given the limitation in further verifying the causal relationship between probiotics and the alleviation of colitis. Thus, there is a need to develop a standardized method for investigating the mechanism of probiotics.
Traditionally, these studies require inoculating certain probiotics into germ-free mice7. However, there are some laboratory limitations in using germ-free mice as receptors for probiotics, such as the low immune capacity and expensive germ-free facilities8. In order to avoid these limitations, an alternative DSS-induced colitis model was established using pseudo-germ-free mice. The pseudo-germ-free mouse model was established by the application of antibiotics as previously described9,10.
In this article, we establish pseudo-germ-free mice with an antibiotic cocktail. We also describe in detail the methodology for establishing and evaluating mouse colitis models and investigate the effects of probiotics on alleviating colitis symptoms. The protocol below also provides the methods of probiotic delivery by gavage.

<table><tbody><tr><td>0.01 M PBS (powder, pH7.2&amp;ndash;7.4)</td><td>Solarbio</td><td>P1010-2L</td><td></td></tr><tr><td>Absolute ethyl alcohol</td><td>Hushi</td><td>64-17-5</td><td></td></tr><tr><td>Acid alcohol fsat differentiation solution</td><td>Beyotime</td><td>No.C0163S</td><td></td></tr><tr><td>Agar</td><td>Sangon Biotech</td><td>9002-18-0</td><td></td></tr><tr><td>Ampicillin</td><td>Solarbio</td><td>69-53-4</td><td>Store at 2&amp;ndash;8 &amp;deg;C</td></tr><tr><td>Anaerobic incubator</td><td>Long Yue</td><td>LA1-3T</td><td></td></tr><tr><td>Dextran sulfate sodium salt colitis grade</td><td>MP Biomedicals</td><td>160110</td><td></td></tr><tr><td>Electrothermal incubator</td><td>SANFA</td><td>HP-050A</td><td></td></tr><tr><td>General purpose tissue fixator</td><td>biosharp</td><td>BL539A</td><td></td></tr><tr><td>Glycerinum</td><td>Hushi</td><td>56-81-5</td><td></td></tr><tr><td>Hematoxylin and eosin staining kit</td><td>Beyotime</td><td>No.C0105</td><td></td></tr><tr><td>Kisser&#039;s Mounting Medium</td><td>Beyotime</td><td>No.C0181</td><td></td></tr><tr><td>Metronidazole</td><td>Solarbio</td><td>443-48-1</td><td>Store at 2&amp;ndash;8 &amp;deg;C</td></tr><tr><td>Neomyein sulfate</td><td>Solarbio</td><td>1405-10-3</td><td>Store at 2&amp;ndash;8 &amp;deg;C</td></tr><tr><td>Oscillating incubator</td><td>Shanghai Zhichu</td><td>ZQLY-180S</td><td></td></tr><tr><td>Sodium chloride</td><td>Sangon Biotech</td><td>7647-14-5</td><td></td></tr><tr><td>Stool occult blood test paper</td><td>Baso</td><td>BA2020B</td><td></td></tr><tr><td>Tryptone</td><td>OXOID</td><td>2285856</td><td></td></tr><tr><td>Vancomycin</td><td>Solarbio</td><td>1404-93-9</td><td>Store at 2&amp;ndash;8 &amp;deg;C</td></tr><tr><td>Xylene</td><td>Hushi</td><td>1330-20-7</td><td></td></tr><tr><td>Yeast extract</td><td>Sangon Biotech</td><td>8013-01-2</td><td></td></tr></tbody></table>

investigating the alleviating effects of bacillus cereus administration on colitis through gut microbiota modulation

Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation

Gut microbiota dysbiosis is thought to exert a role in the progression of colitis. However, the precise standards for probiotic administration in alleviating colitis remain undefined. Most analysis methods rely on limited diversity and abundance of gut microorganisms. Therefore, observational studies cannot establish causation. In this study, we applied antibiotic-induced pseudo-germ-free mice to investigate the role of gut microbiota in regulating the probiotic effects of Bacillus&#160;cereus (B. cereus)&#160;on dextran sulfate sodium (DSS)-induced colitis in mice. This process allows for evaluating the bidirectional regulating effect of B. cereus&#160;supplementation on health and provides stable and reproducible results. Here, the detailed protocols for B. cereus cultivation, gavage operation, stool collection, and antibiotic clearance treatment on colitis mice are provided. The optimization methods are also applicable for other chronic inflammatory-associated disorders. The results showed that B. cereus administration decreased body weight loss, colon length shortening, disease activity index, and histopathological scores. However, treatment with antibiotics suppressed the positive effect of B. cereus on colitis. These results indicate that gut microbiota are needed for the alleviating effects of B. cereus on colitis. Therefore, exploring the beneficial effects of probiotics in this research is a promising approach for developing novel treatment strategies for alleviating the symptoms of chronic inflammatory-associated disorders.

B. cereus supplementation and colitis 
The acute experimental colitis model was induced by the DSS intervention in drinking water. Figure 1A shows the experimental protocol for B. cereus administration to the colitis mouse model. DSS inducement obviously decreased the body weight (Figure 1B) and colon length. The alleviating effect of B. cereus through oral gavage was investigated on the colitis model mice. Compared...

Here, we present a protocol to establish the antibiotic-induced pseudo-germ-free dextran sulfate sodium-induced colitis mouse model to investigate the role of gut microbiota in regulating the positive effects of Bacillus cereus on colitis.

Gut microbiota dysbiosis is thought to exert a role in the progression of colitis. However, the precise standards for probiotic administration in ...

This protocol allows for evaluating the bidirectional regulating effect of probiotic supplementation on health and stable and reproducible results. An alternative DSS induced colitis model was established using pseudo germ free mice in order to avoid some laboratory limitations in using germ free mice as receptors for probiotics. To explore the beneficial effects of probiotics in this technique, it's a promising approach for developing novel treatment strategies for alleviating the symptoms of chronic inflammatory associated disorders.To begin, prepare a cocktail of antibiotics by dissolving ampicillin, neomycin sulfate, metronidazole, and vancomycin in drinking water. After complete dissolution, store the solutions at four degrees Celsius. Put the antibiotic cocktail solutions into a water bottle.Ensure to use brown bottles or wrap the bottles with aluminum foil to protect the antibiotic solutions from light. Place the bottle on top of the mouse cage. To make a 2.5%dextran sulfate sodium solution dissolve 2.5 grams of DSS in 100 milliliters of distilled water.Replace the drinking water with the 2.5%DSS solution in the colitis model mice group. To assess the positive effect of B cereus on alleviating colitis, randomly assign the mice to the following three groups, the control group, the DSS induced colitis model, and probiotic B cereus supplementation for DSS induced mice. To explore the role of gut microbiota in regulating the probiotic effects of B cereus on DSS induced colitis, randomly assign the mice into the following three groups, ABX/control, ABX/DSS, and ABX/B cereus plus DSS.Record the body weight of the mice as the baseline weight after the administration of the antibiotic cocktail. Immediately treat the male C 57 BL six mice with 2.5%DSS solution in drinking water for seven days. Prepare eight 1.5 milliliter micro centrifuge tubes filled with 900 microliters of sterile normal saline.Pipette 100 microliters of logarithmic growth B cereus and dissolve in 900 microliters of sterile normal saline. Serially dilute B cereus using tubes. Plate 40 microliters of each dilution onto the respective LB agar plate labeled with the dilution ratio.Repeat three times for each dilution ratio. Culture the plates in a 37 degrees Celsius constant temperature incubator for 16 hours. Select the plates with approximately 20 to 70 colonies for counting.After the quantification of B cereus, collect one milliliter of B cereus medium containing one times 10 to the ninth CFU and centrifuge at 8, 000 G for 10 minutes. Then wash the bacterial cells two times with sterile water by centrifigation at 8, 000 G for 10 minutes and remove the supernatant. Dilute the concentrated B cereus with sterile normal saline to a final concentration of two times 10 to the eighth CFU per 200 microliters.Pipette the dilution up and down repeatedly to acquire a dispersed B cereus suspension. Wipe the outside of the gavage needle with 70%ethanol and maintain proper dose application. To restrain the mice, pick them up by their tail and grasp the loose skin of the back firmly with the end of the tail fixed between the handler's last two fingers.Keep the mice in a vertical position. Then insert the gavage needle carefully and gently through the mouth into the esophagus. Administer the B cereus solution, withdraw the needle gently, and return the mouse to its cage.Measure the body weight of the mice daily and collect the feces samples immediately in a sterilized centrifuge tube. Determine the fecal occult blood by stool occult blood test paper. Collect 10 milligrams of stool sample on an applicator stick.Put the specimen on the test card and apply a thin smear to the card. Open the back flap and apply the developer over the smear. Fix the mice supine on the operating table and open the peritoneal cavity.Separate the entire colon surgically and measure the length with a ruler. Then gently wash the colon with a five milliliter syringe filled with pre-cooled PBS. De-wax and hydrate the colon sections.Next, stain the colon sections with hematoxylin and eosin. Let two independent experimenters evaluate the histological scores of the sample under a light microscope, Hematoxylin and eosin staining revealed that the colon tissue of the colitis model mice presented crypt loss, goblet cell damage, inflammatory cell infiltration, and the loss of epithelium. B cereus treatment improved DSS induced histopathological damage.The histopathological scores of colitis mice were significantly higher than in the control group. However, the histopathological scores in the B cereus group were significantly lower than in the colitis mice. Mice were randomly assigned into three groups, the body weight loss, DAI scores, and histopathology scores were higher and the colon length was shorter in the ABX/DSS group compared with mice in ABX/control group.The body weight loss, colon length, DAI scores, and histopathology scores were not statistically different between the ABX/DSS and ABX/B cereus plus DSS groups. The present results indirectly suggest that the gut microbiota plays a key role in the positive effects of B cereus on colitis. One of the most important steps is to use Bacillus cereus by gavage method to construct the colitis modeling in mice.The treatment of Bacillus cereus eliminated the DSS induced colitis, which led a foundation for the follow up study of probiotics for the treatment of colitis.

investigating-alleviating-effects-bacillus-cereus-administration-on

Research

JoVE Journal

Biology

Source: Sorokulova, I., et al. Prevention of Heat Stress Adverse Effects in Rats by Bacillus subtilis Strain. J. Vis. Exp. (2016)This video demonstrates rats pre-treated with beneficial bacteria or phosphate-buffered saline (PBS) and exposed to heat stress to evaluate gut barrier integrity. Fewer gut-derived bacterial colonies from the liver of treated rats, in contrast to numerous colonies in control rats, indicate an intact epithelial barrier and minimal bacterial translocation.

Evaluating the Effect of Beneficial Bacteria on Gut Microbial Translocation in Heat-Stressed Rats

This video demonstrates a procedure of fecal microbiota transplantation in an interleukin-10 deficient mouse with colon inflammation. Colonized fecal microbes in the gut release secondary metabolites, eliciting anti-inflammatory cytokine release and reducing colon inflammation.

Evaluating the Effects of Fecal Microbiota Transplantation in an Interleukin-10 Deficient Mouse

Fecal Microbiota Transplantation via colonoscopy is a safe and effective treatment for recurrent and refractory C.difficile infection. A systematic approach to patient and donor screening, preparation of stool, and delivery of the stool during the colonoscopy will maximize therapeutic success.

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Environmental Enrichment (EE) is an animal housing environment that is used to reveal mechanisms that underlie the connections between lifestyle, stress, and disease. This protocol describes a procedure that uses a mouse model of colon tumorigenesis and EE to specifically define alterations in microbiota biodiversity that may impact animal mortality.

A Method to Define the Effects of Environmental Enrichment on Colon Microbiome Biodiversity in a Mouse Colon Tumor Model

This protocol describes an in vitro batch-culture fermentation system of human fecal microbiota, using inulin (a well-known prebiotic and one of the most widely studied microbiota modulators) to demonstrate the use of this system in estimating effects of specific interventions on fecal microbiota composition and metabolic activities.

An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota

In this protocol, a gut microbiota antigen-specific T cell adoptive transfer colitis model is described. CD4+ T cells are isolated from CBir1 TCR transgenic mice. These are specific for an immunodominant gut microbiota antigen CBir1 flagellin, which is transferred into recipient Rag1-/- mice, leading to intestinal inflammation.

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice

The interaction of genetic susceptibility, mucosal immunity, and intestinal microecological environment is involved in the pathogenesis of inflammatory bowel disease (IBD). In this study, we applied fecal microbiota transplantation to IL-10 deficient mice and investigated its impact on colonic inflammation and heart function.

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

This protocol describes the necessary steps for colonization of mice with pks+ Escherichia coli under non-inflammatory conditions, as well as non-invasive methods for validation of colonization and assessment of pks+ E. coli expansion in feces.

Colonization with Murine pks+ Escherichia coli under Non-Inflammatory Conditions

This video illustrates the technique for extracting DNA from the species of microbes resident in the termite hindgut.  The preparation of a wet mount slide, which is useful for visualizing the gut microbial community is also illustrated, and a tour through the species-rich gut environment is given.

Extracting DNA from the Gut Microbes of the Termite (Zootermopsis Angusticollis) and Visualizing Gut Microbes

The effect of substrata stiffness on cellular function can be modeled in vitro using polyacrylamide hydrogels of varying compliances.

Studying the Effects of Matrix Stiffness on Cellular Function using Acrylamide-based Hydrogels

Learn to establish a DSS-induced colitis model in antibiotic-treated mice to evaluate Bacillus cereus probiotic effects. This method reveals how gut microbiota mediates protective outcomes in inflammatory bowel disease research.

Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation

Explore More Videos